Ledger.Open graph →

SEC Form D · filed February 16, 2016

Chase Pharmaceuticals Corp

Offering

$613K

Sold

—

Exemption

Rule 506(b)

Industry

Pharmaceuticals

Location

WASHINGTON, Washington, D.C.

Type

—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (25)

Stephen N. Cunningham · Washington, DC, Washington, D.C.Director John M. Reher · Washington, DC, Washington, D.C.Director Nayan G. Parekh · Washington, DC, Washington, D.C.Director Douglas Ingram · Washington, DC, Washington, D.C.Exec · Director Kathleen N. Clarence-Smith · Washington, DC, Washington, D.C.Exec Vikram M. Sudarsan · Washington, DC, Washington, D.C.Director Thomas N. Chase · Washington, DC, Washington, D.C.Exec · Director Karoly N. Nikolich · Washington, DC, Washington, D.C.Director Raphael M. Wisniewski · Washington, DC, Washington, D.C.Director Bob M. Flannery · Chicago, ILDirector Scott A. Mcfetridge · BOSTON, MAExec Jason A. Darrah · St. Louis, MODirector A. T. Spitzer · St. Louis, MODirector Scott B. Garfield · BOSTON, MAExec · Director Joseph W. Panter · Paradise Valley, AZDirector Thomas F. Mcdevitt · Southport, CTDirector Michael H. House · Southport, CTDirector Marc Platt · Universal City, CADirector Frank Yulin Yao · Central, Hong KongExec · Director Brian A. Albert · BOSTON, MADirector Saverio R. Costa · BOSTON, MADirector Stephen J. Blewitt · BOSTON, MAExec · Director Benjamin Blumenthal · Carrollton, TXDirector Jeanine Johnson · Carrollton, TXExec Jared L. Lucero · Alpine, UTExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗